PYC PYC Therapeutics Ltd
- 0.145
- 0.0000.00%
PYC Therapeutics Ltd News
The Five-year Returns Have Been Stellar for PYC Therapeutics (ASX:PYC) Shareholders Despite Underlying Losses Increasing
PYC Therapeutics Secures US FDA's Rare Pediatric Disease Designation for Eye Disease Medication; Shares Hit 52-Week High
PYC Therapeutics Ltd: Appendix 4E and Audited Financial Statements
PYC Therapeutics to Conduct Human Trials for Eye Disease Drug Candidate
Why Actinogen, Aurizon, Beach Energy, and PYC Shares Are Sinking Today
PYC Therapeutics Completes Small Shareholding Sale Facility
PYC Therapeutics Advances Key Drug Programs
PYC Therapeutics Completes Initial Dosing for Retinitis Pigmentosa Study
PYC Therapeutics Begins Multiple Dose Trial for Blinding Eye Disease Drug
PYC Therapeutics Advances Trial for Drug Candidate; Shares Up 4%
Canaccord Genuity Starts PYC Therapeutics at Buy With AU$0.22 Price Target
Why IDP Education, Novonix, PYC, and Regis Resources Share Are Racing Higher
Stocks of the Hour: PYC Therapeutics, Caprice Resources, Walkabout Resources
PYC Therapeutics Advances Groundbreaking Treatment for Phelan-McDermid Syndrome
PYC Achieved Protein-restoration on Genetic Condition PMS Ahead of Human Trialling
PYC Therapeutics's Fourth Neurodevelopmental Disorder Drug Candidate Moves Closer to Human Trials; Shares Up 10%
2 ASX Penny Stocks to Consider Buying While Their Prices Are This Cheap
Why Appen, Mayne Pharma, Playside, and PYC Shares Are Storming Higher
Guess Which ASX All Ords Insider Just Bought 50 Million Shares in Their Company
PYC Therapeutics Started at Buy by Bell Potter >PYC.AU
Analysis
Price Target
No Data
No Data